Back to Agenda
Fighting Medical Disinformation (Without Actually Starting a Fight)
Session Chair(s)
Lindsay McNair, MD, MPH, MS
Principal Consultant
Equipoise Consulting, United States
We’ll discuss whether drug development professionals have an ethical obligation to confront misinformation, effective ways to approach these conversations without confrontation, and what techniques and messages work best in different settings.
Learning Objective : Explain the ethical principles that underlie the obligation of drug development professionals to combat disinformation; Discuss best practices for successful encounters in combatting disinformation; Distinguish the application of different practices in their most appropriate settings
Speaker(s)
Effective Messaging to Combat Scientific Mis/Disinformation
Joseph Cappella
University of Pennsylvania, United States
Gerald R. Miller Professor Emeritus of Communication
Perspectives of a Science Reporter
Sydney Lupkin
National Public Radio (NPR), United States
NPR Pharmaceutical Correspondent
Have an account?